In conclusion, the expression of the receptor tyrosine kinase ROR1 is associated with a poor prognosis in several malignancies including DLBCL and of importance for tumor cell proliferation survival, metabolism and epithelial-mesenchymal-transition (EMT). This evidence concerns the gene ROR1 and diffuse large B-cell lymphoma.